CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE…

Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride Tablets

Read the official FDA notice

Published
1 Jan 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-861-01

chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-862-01

Brand / company
Glenmark Pharmaceuticals Inc., USA
Codes / lots
Lot#: 17230132, Exp 12/2024; 17230449, Exp 01/2025 | Lot#: 17230133, Exp 12/31/2024
Distribution
USA Nationwide
Recall status
Completed

Source: U.S. Food and Drug Administration, published 1 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.